Biotechnology and Medical Research (TRBC)

French pharma group Ipsen closes in on its next drug deals

French pharma group Ipsen closes in on its next drug deals

Published 14/11/2018

LONDON (Reuters) - French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of [more…]

Novartis abandons effort for U.S. approval of biosimilar rituximab

Novartis abandons effort for U.S. approval of biosimilar rituximab

Published 02/11/2018

(Reuters) - Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of [more…]

FDA approves Pfizer’s treatment for certain lung cancer patients

FDA approves Pfizer’s treatment for certain lung cancer patients

Published 02/11/2018

(Reuters) - Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation [more…]

FDA panel recommends Sage’s postpartum depression treatment

FDA panel recommends Sage’s postpartum depression treatment

Published 02/11/2018

(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc’s experimental treatment for postpartum depression, saying the [more…]

FDA approves AcelRx Pharma’s opioid pain drug

FDA approves AcelRx Pharma’s opioid pain drug

Published 02/11/2018

(Reuters) - The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc’s opioid-based treatment for pain to be used under strict medical supervision, [more…]

Trevena opioid painkiller fails to win FDA approval, shares plunge

Trevena opioid painkiller fails to win FDA approval, shares plunge

Published 02/11/2018

(Reuters) - Trevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing [more…]

Drugmakers tout new medicines as eye disease battle intensifies

Drugmakers tout new medicines as eye disease battle intensifies

Published 29/10/2018

ZURICH (Reuters) - Switzerland’s Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as [more…]

AstraZeneca’s Lynparza shown to put brakes on ovarian cancer

AstraZeneca’s Lynparza shown to put brakes on ovarian cancer

Published 21/10/2018

MUNICH (Reuters) - An AstraZeneca drug that blocks a cancer cell’s ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening [more…]

Roche takes on Loxo, Bayer in gene-defined cancer class

Roche takes on Loxo, Bayer in gene-defined cancer class

Published 21/10/2018

MUNICH (Reuters) - Roche’s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified [more…]

Roche scores win in slowing aggressive type of breast cancer

Roche scores win in slowing aggressive type of breast cancer

Published 20/10/2018

ZURICH/MUNICH (Reuters) - An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news [more…]